Issue 40, 2016

Cephalosporins inhibit human metallo β-lactamase fold DNA repair nucleases SNM1A and SNM1B/apollo

Abstract

Bacterial metallo-β-lactamases (MBLs) are involved in resistance to β-lactam antibiotics including cephalosporins. Human SNM1A and SNM1B are MBL superfamily exonucleases that play a key role in the repair of DNA interstrand cross-links, which are induced by antitumour chemotherapeutics, and are therefore targets for cancer chemosensitization. We report that cephalosporins are competitive inhibitors of SNM1A and SNM1B exonuclease activity; both the intact β-lactam and their hydrolysed products are active. This discovery provides a lead for the development of potent and selective SNM1A and SNM1B inhibitors.

Graphical abstract: Cephalosporins inhibit human metallo β-lactamase fold DNA repair nucleases SNM1A and SNM1B/apollo

Supplementary files

Article information

Article type
Communication
Submitted
19 Jan 2016
Accepted
18 Apr 2016
First published
18 Apr 2016
This article is Open Access
Creative Commons BY license

Chem. Commun., 2016,52, 6727-6730

Author version available

Cephalosporins inhibit human metallo β-lactamase fold DNA repair nucleases SNM1A and SNM1B/apollo

S. Y. Lee, J. Brem, I. Pettinati, T. D. W. Claridge, O. Gileadi, C. J. Schofield and P. J. McHugh, Chem. Commun., 2016, 52, 6727 DOI: 10.1039/C6CC00529B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements